Bio-Rad Laboratories Inventory Turnover Ratio 2006-2020 | BIO
Current and historical inventory turnover ratio for Bio-Rad Laboratories (BIO) from 2006 to 2020. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period. Bio-Rad Laboratories inventory turnover ratio for the three months ending March 31, 2020 was 0.46.
| Bio-Rad Laboratories Inventory Turnover Ratio Historical Data | |||
|---|---|---|---|
| Date | |||
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $14.566B | $2.312B |
| Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide. The company's products are used to separate complex chemical and biological materials, and to identify, analyze, and purify their components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment offers electrophoresis, image analysis, molecular detection, chromatography, gene transfer, sample preparation, and amplification products and services. The Clinical Diagnostics segment provides control, autoimmune, diabetes, and blood virus testing products. Bio-Rad is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. The company is headquartered in Hercules, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $167.899B | 29.12 |
| Medtronic (MDT) | Ireland | $132.114B | 21.48 |
| Stryker (SYK) | United States | $73.365B | 23.81 |
| Boston Scientific (BSX) | United States | $53.161B | 24.99 |
| Baxter (BAX) | United States | $45.654B | 27.87 |
| Lonza Group Ag (LZAGY) | Switzerland | $36.676B | 0.00 |
| Terumo (TRUMY) | Japan | $29.978B | 0.00 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $28.400B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $26.077B | 16.41 |
| ResMed (RMD) | United States | $23.266B | 36.72 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $17.849B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $14.583B | 0.00 |
| Insulet (PODD) | United States | $11.896B | 1178.56 |
| DiaSorin S.p.A (DSRLF) | Italy | $10.630B | 0.00 |
| Perrigo (PRGO) | Ireland | $7.466B | 13.36 |
| Quidel (QDEL) | United States | $7.350B | 57.76 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $7.281B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $6.767B | 19.08 |
| William Demant Holdings (WILYY) | Denmark | $6.670B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $6.590B | 34.05 |
| Canopy Growth (CGC) | Canada | $6.093B | 0.00 |
| Haemonetics (HAE) | United States | $5.517B | 33.14 |
| ICU Medical (ICUI) | United States | $4.158B | 30.34 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.796B | 0.00 |
| Neogen (NEOG) | United States | $3.754B | 63.59 |
| Agios Pharmaceuticals (AGIO) | United States | $3.564B | 0.00 |
| Envista Holdings (NVST) | United States | $3.366B | 0.00 |
| NuVasive (NUVA) | United States | $3.106B | 24.94 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $2.909B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.150B | 37.19 |
| TG Therapeutics (TGTX) | United States | $2.055B | 0.00 |
| AtriCure (ATRC) | United States | $1.916B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $1.428B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.366B | 0.00 |
| NanoString Technologies (NSTG) | United States | $1.152B | 0.00 |
| Aphria (APHA) | Canada | $1.130B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.060B | 21.13 |
| Cerus (CERS) | United States | $1.020B | 0.00 |
| MacroGenics (MGNX) | United States | $0.945B | 0.00 |
| InMode (INMD) | Israel | $0.937B | 19.80 |
| OraSure Technologies (OSUR) | United States | $0.902B | 181.75 |
| PetIQ (PETQ) | United States | $0.871B | 25.15 |
| Omeros (OMER) | United States | $0.811B | 0.00 |
| Quanterix (QTRX) | United States | $0.781B | 0.00 |
| DFB Healthcare Acquisitions (AHCO) | United States | $0.735B | 124.46 |
| VAREX IMAGING (VREX) | United States | $0.734B | 18.21 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.701B | 50.25 |
| Meridian Bioscience (VIVO) | United States | $0.662B | 24.94 |
| Zynex (ZYXI) | United States | $0.644B | 64.67 |
| Vapotherm (VAPO) | United States | $0.567B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.546B | 10.98 |
| LeMaitre Vascular (LMAT) | United States | $0.543B | 30.91 |
| Surmodics (SRDX) | United States | $0.503B | 60.62 |
| Owens & Minor (OMI) | United States | $0.500B | 13.22 |
| Repro-Med Systems (KRMD) | United States | $0.402B | 337.33 |
| Cytosorbents (CTSO) | United States | $0.370B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.362B | 26.32 |
| BioLife Solutions (BLFS) | United States | $0.336B | 149.55 |
| Viemed Healthcare (VMD) | United States | $0.321B | 28.72 |
| Organigram Holdings (OGI) | Canada | $0.306B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.283B | 0.00 |
| HEXO (HEXO) | $0.258B | 0.00 | |
| Female Health (VERU) | United States | $0.247B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.233B | 129.00 |
| Chimerix (CMRX) | United States | $0.193B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.169B | 0.00 |
| Evolus (EOLS) | United States | $0.154B | 0.00 |
| Fonar (FONR) | United States | $0.154B | 13.66 |
| Bovie Medical (APYX) | United States | $0.152B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.148B | 0.00 |
| Exagen (XGN) | United States | $0.146B | 0.00 |
| Surface Oncology (SURF) | United States | $0.145B | 0.00 |
| United Health Products (UEEC) | United States | $0.134B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.127B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.123B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.109B | 0.00 |
| Brainsway (BWAY) | Israel | $0.084B | 0.00 |
| Wound Management Technologies (SMTI) | United States | $0.074B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.073B | 0.00 |
| United-Guardian (UG) | United States | $0.072B | 16.77 |
| Nephros (NEPH) | United States | $0.070B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.066B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.045B | 0.00 |
| ImmuCell (ICCC) | United States | $0.033B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.030B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.025B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.021B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.016B | 0.00 |
| Myomo (MYO) | United States | $0.011B | 0.00 |
| Senestech (SNES) | United States | $0.006B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.004B | 0.00 |
